|

Etoposide + cisplatin/carboplatin Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Peking University Cancer Hospital & Institute1

Indications

  • Limited-stage Small Cell Lung Cancer (LS-SCLC)1
  • Lung Cancer1
  • Cancer1

Other1 trial

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.